Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
Summary
This regulation extends a temporary COVID-19 policy that allows doctors to prescribe certain controlled medications (like pain pills and ADHD drugs) through telemedicine without an in-person visit. The extension keeps this flexibility in place for patients who need ongoing treatment but may have difficulty getting to a doctor's office.
Key Points
- 1Doctors can continue prescribing controlled medications via video or phone visits without requiring a first in-person appointment
- 2Applies to prescription drugs that are typically restricted, such as opioids for pain management and stimulants for ADHD
- 3This is the fourth time the government has extended this emergency flexibility since the COVID-19 pandemic began
- 4Patients can access necessary medications from home, which is especially helpful for those with mobility issues or transportation barriers
- 5The extension is temporary and may require future renewals as the government periodically reviews the policy
Impact Assessment
If you are a Healthcare Provider, this means you can continue prescribing certain controlled medications via telemedicine without requiring patients to visit your office in person. If you are a Consumer, this means you can continue receiving prescriptions for ongoing treatments like pain management or ADHD medication through telehealth appointments.
National
Minimal
Key Dates
December 31, 2025
Regulatory Connections
Patient Protection and Affordable Care Act, Benefit and Payment Parameters for 2027 and Basic Health Program
Annual Civil Monetary Penalties Inflation Adjustment
Hearings, Meetings, Proceedings, etc.: Health Insurance Portability and Accountability Act Privacy Rule; Tribal Consultation
Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability; Withdrawal
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.